Literature DB >> 3438223

Oral administration of codeine in the presence of ethanol: a pharmacokinetic study in man.

E Bodd1, K M Beylich, A S Christophersen, J Mørland.   

Abstract

Three healthy male volunteers were given a codeine (1 mg/kg) solution in the absence and presence of ethanol in a cross-over designed study. The blood ethanol concentration was kept at approximately 16 mM for 8 hrs. Blood samples were taken at several occasions during the first day after the codeine administration. Urine was sampled during three days. There were no significant differences in the area under serum concentration versus time curve in the absence and presence of ethanol with respect to free codeine, total codeine and total morphine. The fraction of codeine glucuronized in serum (approximately 94%), the maximum serum concentration of free (0.34 microM) and total codeine (6.3 microM), the time to reach the maximum serum concentration values (approximately 65 min.) were also similar in the absence and presence of ethanol. The accumulated percentage of the codeine dose given which was found as codeine and morphine and their conjugates in the urine ranged from 50 to 91 percent in the different subjects. The accumulated percentage of the administered codeine dose found as free morphine in the urine, was significantly lower in the ethanol exposed individuals (0.18 +/- 0.03%) compared to the controls (0.39 +/- 0.09%). The percentage of the codeine dose found in the urine in the control situation as free codeine (5.2 +/- 2.2%) was not statistically different from the amount found in the urine after ethanol treatment (4.3 +/- 2.0%). The percentage glucuronized morphine (95.3 +/- 0.4%) and codeine (91.9 +/- 2.2%) in the urine in the absence of ethanol was similar to glucuronized morphine (95.3 +/- 2%) and codeine (93.1 +/- 3%) after ethanol exposure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3438223     DOI: 10.1111/j.1600-0773.1987.tb01822.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  7 in total

1.  Lack of effect of paracetamol on the pharmacokinetics and metabolism of codeine in man.

Authors:  A Somogyi; F Bochner; Z R Chen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

3.  Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.

Authors:  Z R Chen; A A Somogyi; G Reynolds; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 4.  Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors:  V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

5.  Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.

Authors:  Q Y Yue; J Hasselström; J O Svensson; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

6.  Less glucuronidation of morphine in the presence of ethanol in vivo.

Authors:  Gudrun Høiseth; Jannike Mørch Andersen; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

7.  Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.

Authors:  Salvador F Ausar; Shaolong Zhu; Jessica Duprez; Michael Cohen; Thomas Bertrand; Valérie Steier; Derek J Wilson; Stephen Li; Anthony Sheung; Roger H Brookes; Artur Pedyczak; Alexey Rak; D Andrew James
Journal:  Commun Biol       Date:  2020-08-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.